Cognition Therapeutics, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.06 | $-0.04 | +33.3% | Beat |
| Q12026 FY2026 | $-0.06 | $-0.05 | +16.7% | Beat |
| Q42025 FY2025 | $-0.06 | $-0.02 | +66.7% | Beat |
Back to CGTX overview · CGTX holders · CGTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.